Pneumoconiosis and Dust Exposure China Cohort
PANDECT
1 other identifier
observational
2,000
1 country
1
Brief Summary
The primary objective of this study is to characterize the demographic and clinical features of patients with occupational pneumoconiosis (hereinafter referred to as pneumoconiosis) in China. Secondary objectives include: 1) to describe the natural course of pneumoconiosis; 2) to evaluate the prognosis of pneumoconiosis patients; and 3) to assess complications and comorbidities in pneumoconiosis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 28, 2021
CompletedFirst Submitted
Initial submission to the registry
June 23, 2025
CompletedFirst Posted
Study publicly available on registry
July 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2030
ExpectedJuly 22, 2025
July 1, 2025
4.8 years
June 23, 2025
July 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Pulmonary function test
Pulmonary function tests (PFTs) are utilized to assess the severity of the patient's condition, monitor disease progression, guide therapeutic decision-making, and evaluate prognosis.
3 years
Secondary Outcomes (1)
Number of patients
6 years
Study Arms (3)
Patients with pneumoconiosis
This group is composed of patients with pneumoconiosis.
Dust exposure group
This group is composed of patients exposed to dust.
Healthy control group
This group is composed of healthy control subjects.
Eligibility Criteria
Patients were selected during physical examinations or during hospitalization from medical organization.
You may qualify if:
- Diagnosed as pneumoconiosis
You may not qualify if:
- Incomplete occupational history information
- Has participated in any interventional clinical research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- China-Japan Friendship Hospitallead
- KaiLuan General Hospitalcollaborator
- The First Affiliated Hospital of Shanxi Medical Universitycollaborator
- Weifang Respiratory Disease Hospitalcollaborator
- Hubei Hospital of Traditional Chinese Medicinecollaborator
- Hunan Prevention and Treatment Institute for Occupational Diseases, Chinacollaborator
- The first affiliated hospital of chongqing medical and pharmaceutical collegecollaborator
- Centers for Disease Control and Prevention, Chinacollaborator
- Shandong Gold Mining Company Occupational Disease Precention Hospitalcollaborator
- Shandong Province Hospital of occupational diseasescollaborator
- The Second Hospital of Heilongjiang Provincecollaborator
Study Sites (1)
China-Japan Friendship Hospital
Beijing, Beijing Municipality, 100029, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief physician
Study Record Dates
First Submitted
June 23, 2025
First Posted
July 22, 2025
Study Start
May 28, 2021
Primary Completion
March 31, 2026
Study Completion (Estimated)
May 31, 2030
Last Updated
July 22, 2025
Record last verified: 2025-07